1. Comi G, Radaelli M, Soelberg Sørensen P. Evolving concepts in the treatment of relapsing multiple sclerosis. Lancet. 2017 Apr 1;389(10076):1347-1356. doi: 10.1016/S0140-6736(16)32388-1. Epub 2016 Nov 24. PMID: 27889192.

2. Gavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut et al. Brain health: time matters in multiple sclerosis, Multiple Sclerosis and Related Disorders, Vol 9, Supplement 1,2016,S5-S48, doi.org/10.1016/j.msard.2016.07.003.

3. Adaptat Giovannoni G. Curr Opin Neurol. 2018 Jun;31(3):233-243

• JCV, virusul John Cunningham
• DMT, disease-modifying therapy (română: terapie modificatoare de boală), SM, scleroză multiplă
• NEDA = no evidence of disease activity (română: fără evidența activității bolii); LCR, lichid cefalo-rahidian, Nfl, neurofilamente, IFN-β = interferon-beta; GA, glatiramer acetat; Teri, teriflunomide; DMF, dimetil fumarat; Fingo, fingolimod; Nz = natalizumab; Az, alemtuzumab; Clad, oral cladribină, Ocr = ocrelizumab.